News 9 Oct 2026 DNDi 2026 Projects of the Year recognize teams and partners for their work to advance an open-science antiviral for future coronavirus pandemics and a single-dose treatment for sleeping sickness
Scientific articles 9 Oct 2026 A Perspective on Biomarkers, Candidates for Surrogate End Points to Accelerate Successful Development of New Antiparasitic Agents for the Treatment of Chronic Chagas Disease ACS Infectious Diseases
Press releases 6 Oct 2026 Ghana’s KNUST and DNDi partner to accelerate drug discovery for neglected diseases in Africa
Scientific articles 5 Oct 2026 Winning the endgame against sleeping sickness: Efficacy profiling of acoziborole against African trypanosomes with the focus on Trypanosoma brucei rhodesiense PLoS Neglected Tropical Diseases
Statements 25 Sep 2026 DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly
In the media 24 Sep 2026 De Etiopía a Lleida: la desigualdad mata tanto como los virus durante una pandemia El País
Scientific articles 22 Sep 2026 Efficacy and safety of alternative benznidazole and nifurtimox regimens for adults with chronic Trypanosoma cruzi infection (TESEO): an open-label, randomised, non-inferiority phase 2b trial The Lancet Infection Diseases
Scientific articles 19 Sep 2026 Thermotherapy compared with intralesional sodium stibogluconate for Leishmania aethiopica cutaneous Leishmaniasis in Ethiopia: A phase II randomized controlled trial BMC Medicine
News 15 Sep 2026 New DNDi report: Implementing Article 9.5 of the WHO Pandemic Agreement – building on current policy and practice for publicly funded R&D
In the media 9 Sep 2026 Des acteurs pharmaceutiques à but non lucratif s’allient pour faire face à la baisse des financements Swissinfo
Scientific articles 1 Sep 2026 Analysis of the therapeutic gap for Trypanosoma cruzi infection inColombia (2012 – 2022) Memórias do Instituto Oswaldo Cruz
News 30 Jan 2026 Imperial and DNDi strengthen partnership to accelerate treatments for neglected diseases
News 27 Jan 2026 DNDi and APHRC sign MoU to forge strategic alliance to bridge research and capacity enhancement gaps
News 4 Dec 2025 Dr Javid Abdelmoneim, Datuk Dr Mahathar bin Abd Wahab, Dr Taruna Madan, Violet Naanyu, and Dr Mario Santos Moreira join the Board of Directors at DNDi
News 26 Nov 2025 DNDi statement on the approval of the Instituto Butantan’s dengue vaccine and the need for a dengue treatment
News 17 Nov 2025 New DNDi report: Open science in a closed world – lessons and opportunities for securing openness and equitable access in R&D collaborations
News 3 Oct 2025 DNDi 2025 Projects of the Year recognize contributions of DNDi teams and partners working to deliver urgently needed innovations for people affected by Chagas disease and river blindness
News 8 Aug 2025 Statement from DNDi on Kenya’s elimination of rhodesiense sleeping sickness as a public health problem
News 5 Aug 2025 ADB and DNDi sign MoU to advance healthcare cooperation on neglected diseases in Asia and the Pacific
News 10 Jul 2025 LEO Foundation partners with DNDi to develop breakthrough drug discovery model for mycetoma
